Phase 3 Alzheimer's Disease Trial, Recruiting NCT06530732 Sponsor: Zhejiang Provincial People's Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 3 Alzheimer's Disease Trial, Recruiting

NCT06530732
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Alzheimer's disease based on biological markers and clinical symptoms
  • People who are over 35 years old and have scored 26 or below on a standard memory and thinking assessment (MMSE or MoCA test)
  • People for whom the patient or a family member has signed a consent form agreeing to take part

Who may not be able to join:

  • People who are unable to cooperate with a lumbar puncture (a procedure that collects fluid from the lower spine)
  • People whose memory or thinking problems are caused by a brain or nervous system infection such as HIV or neurosyphilis, or by conditions such as autoimmune encephalitis, diabetes, or thyroid problems
  • People who have serious problems with a major organ such as the heart, lungs, liver, or kidneys
  • People who have a condition that affects blood clotting, or who have other medical reasons that make surgery unsafe
  • People who would be unable to attend and fully participate in follow-up appointments during the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Zhejiang Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
1 July 2024
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The rate of change in the total score of the Clinical Dementia Rating Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov